PMI Impact Malaria in Senegal

PMI Impact Malaria (IM) is the flagship global service delivery project of the U.S. President’s Malaria Initiative (PMI). To fight malaria and save lives, IM is supporting Senegal’s national malaria control program (NMCP) in its efforts to strengthen malaria service delivery.

To advance malaria service delivery in Senegal, IM is working to improve drug-based prevention by conducting a study on the effect that time-limited mass drug administration (MDA) of two antimalarials, dihydroartemisinin-piperaquine and single low-dose primaquine, has on malaria transmission rates in a moderate-low transmission setting. This study will inform Senegal's NMCP on the potential impact of time-limited MDA to accelerate transmission reduction and thus transition from control to elimination activities.

Resources

Senegal Malaria Summary PMI Webpage
Malaria Service Delivery Photos PMI Impact Malaria Photo Library

Malaria Country Context

Almost all of Senegal’s roughly 15.8 million people are vulnerable to malaria. The country can be divided into two epidemiological zones: the tropical zone, with year-round transmission peaking during the rainy season and lower transmission during the rest of the year; and the Sahelian zone, with high transmission toward the end of, and immediately after, the rainy season and very low transmission during the rest of the year. The malaria parasite species Plasmodium falciparum causes the majority of infections.

Malaria is still a major cause of morbidity and mortality in Senegal, especially among vulnerable groups such as an estimated 3 million children less than five years of age and 600,000 pregnant women. In 2018, there were an estimated one million cases of malaria in the country. However, testing rates remain low, with the country’s health facilities reporting 396,000 confirmed malaria cases that same year.

This is PMI Impact Malaria’s geographic coverage in Senegal:

Photo Credit: PMI, Senegal

Sources: PMI’s Senegal Country Brief, PMI’s Senegal Malaria Operational Plan FY 2020, 2019 World Malaria Report Senegal Country Profile, PMI Impact Malaria Senegal, and Senegal's NMCP

The information provided on this website is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development or the U.S. Government.

Memphis Web Design by Speak